Piero Portincasa to Italy
This is a "connection" page, showing publications Piero Portincasa has written about Italy.
Connection Strength
0.157
-
Multiplying effects of COVID-19 lockdown on metabolic risk and fatty liver. Eur J Clin Invest. 2021 Jul; 51(7):e13597.
Score: 0.040
-
Bismuth-based quadruple therapy following H. pylori eradication failures: a multicenter study in clinical practice. J Gastrointestin Liver Dis. 2017 Sep; 26(3):225-229.
Score: 0.031
-
A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy. Eur J Clin Invest. 2017 Sep; 47(9):622-629.
Score: 0.030
-
Eradication rates in Italian subjects heterogeneously managed for Helicobacter pylori infection. Time to abandon empiric treatments in Southern Europe. J Gastrointestin Liver Dis. 2017 Jun; 26(2):129-137.
Score: 0.030
-
COVID-19, internists and resilience: the north-south Italy outbreak. Eur J Clin Invest. 2020 Jul; 50(7):e13299.
Score: 0.009
-
Recurrence of COVID-19 after recovery: a case report from Italy. Infection. 2020 12; 48(6):965-967.
Score: 0.009
-
Sequential therapy for first-line Helicobacter pylori eradication: 10- or 14-day regimen? J Gastrointestin Liver Dis. 2019 Mar; 28(1):11-14.
Score: 0.008